| Search-and-replace genome editing without double-strand breaks or donor DNA AV Anzalone, PB Randolph, JR Davis, AA Sousa, LW Koblan, JM Levy, ... Nature 576 (7785), 149-157, 2019 | 4149 | 2019 |
| Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors AV Anzalone, LW Koblan, DR Liu Nature biotechnology 38 (7), 824-844, 2020 | 1930 | 2020 |
| Prime genome editing in rice and wheat Q Lin, Y Zong, C Xue, S Wang, S Jin, Z Zhu, Y Wang, AV Anzalone, ... Nature biotechnology 38 (5), 582-585, 2020 | 763 | 2020 |
| Engineered pegRNAs improve prime editing efficiency JW Nelson, PB Randolph, SP Shen, KA Everette, PJ Chen, AV Anzalone, ... Nature biotechnology 40 (3), 402-410, 2022 | 517 | 2022 |
| Super-multiplex vibrational imaging L Wei, Z Chen, L Shi, R Long, AV Anzalone, L Zhang, F Hu, R Yuste, ... Nature 544 (7651), 465-470, 2017 | 491 | 2017 |
| Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing AV Anzalone, XD Gao, CJ Podracky, AT Nelson, LW Koblan, A Raguram, ... Nature biotechnology 40 (5), 731-740, 2022 | 404 | 2022 |
| Efficient C• G-to-G• C base editors developed using CRISPRi screens, target-library analysis, and machine learning LW Koblan, M Arbab, MW Shen, JA Hussmann, AV Anzalone, JL Doman, ... Nature biotechnology 39 (11), 1414-1425, 2021 | 191 | 2021 |
| PrimeDesign software for rapid and simplified design of prime editing guide RNAs JY Hsu, J Grünewald, R Szalay, J Shih, AV Anzalone, KC Lam, MW Shen, ... Nature Communications 12 (1), 1034, 2021 | 171 | 2021 |
| Efficient prime editing in mouse brain, liver and heart with dual AAVs JR Davis, S Banskota, JM Levy, GA Newby, X Wang, AV Anzalone, ... Nature biotechnology 42 (2), 253-264, 2024 | 107 | 2024 |
| A common diaryl ether intermediate for the gram-scale synthesis of oxazine and xanthene fluorophores. AV Anzalone, TY Wang, Z Chen, VW Cornish Angewandte Chemie International Edition 52 (2), 2013 | 51 | 2013 |
| Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity GR Ott, R Tripathy, M Cheng, R McHugh, AV Anzalone, TL Underiner, ... Acs Medicinal Chemistry Letters 1 (9), 493-498, 2010 | 49 | 2010 |
| Novel 2, 3, 4, 5-tetrahydro-benzo [d] azepine derivatives of 2, 4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models EF Mesaros, JP Burke, JD Parrish, BJ Dugan, AV Anzalone, TS Angeles, ... Bioorganic & medicinal chemistry letters 21 (1), 463-466, 2011 | 40 | 2011 |
| Interrogation of Eukaryotic Stop Codon Readthrough Signals by in Vitro RNA Selection AV Anzalone, S Zairis, AJ Lin, R Rabadan, VW Cornish Biochemistry 58 (8), 1167-1178, 2019 | 39 | 2019 |
| Reprogramming eukaryotic translation with ligand-responsive synthetic RNA switches AV Anzalone, AJ Lin, S Zairis, R Rabadan, VW Cornish Nature methods 13 (5), 453-458, 2016 | 37 | 2016 |
| A prime editor mouse to model a broad spectrum of somatic mutations in vivo ZA Ely, N Mathey-Andrews, S Naranjo, SI Gould, KL Mercer, GA Newby, ... Nature biotechnology 42 (3), 424-436, 2024 | 27 | 2024 |
| Methods and compositions for prime editing nucleotide sequences DR Liu, AV Anzalone, G Newby, K Everette US Patent 11,447,770, 2022 | 26 | 2022 |
| Synthesis of photoactivatable azido-acyl caged oxazine fluorophores for live-cell imaging AV Anzalone, Z Chen, VW Cornish Chemical Communications 52 (60), 9442-9445, 2016 | 21 | 2016 |
| Methods and compositions for prime editing nucleotide sequences DR Liu, AV Anzalone, JW Nelson US Patent 11,643,652, 2023 | 17 | 2023 |
| Synthetic studies toward 3-(Acylamino)-1H-indazoles and development of a one-pot, Microwave-assisted, oxadiazole condensation/Boulton-Katritzky rearrangement GR Ott, AV Anzalone Synlett 2011 (20), 3018-3022, 2011 | 14 | 2011 |
| Methods and compositions for prime editing nucleotide sequences DR Liu, AV Anzalone US Patent 11,795,452, 2023 | 12 | 2023 |
